Theravance Biopharma Inc
Healthcare · EUR · F
Price
€14.003
Cap
€876.92M
Earnings
—
30d Trend
-0.1%
BRAIN47 SIGNAL
Raw weighted: 54×Macro 0.99 (−1%)=53
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Long-term compounder with 5.0% yield
BRAIN47'S ASSESSMENT
I rate Theravance Biopharma Inc at 53/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is quality at 89/100. I classify this as a speculative position with the strongest thesis on a long-term horizon.
DETAILED ANALYSIS
Long-term compounder with 5.0% yield. Quality (89) and Momentum (62) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. I classify this as a speculative position — elevated volatility at 60% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.